nodes	percent_of_prediction	percent_of_DWPC	metapath
Pemetrexed—SLC46A1—Sulfasalazine—Crohn's disease	0.506	0.629	CbGbCtD
Pemetrexed—SLC29A1—Mercaptopurine—Crohn's disease	0.298	0.371	CbGbCtD
Pemetrexed—GART—One Carbon Metabolism—DNMT3A—Crohn's disease	0.00615	0.123	CbGpPWpGaD
Pemetrexed—Creatinine renal clearance decreased—Mesalazine—Crohn's disease	0.00583	0.0681	CcSEcCtD
Pemetrexed—ATIC—One Carbon Metabolism—DNMT3A—Crohn's disease	0.00426	0.0851	CbGpPWpGaD
Pemetrexed—GART—mammalian vulva—Crohn's disease	0.00355	0.0642	CbGeAlD
Pemetrexed—GART—lymphoid tissue—Crohn's disease	0.00315	0.057	CbGeAlD
Pemetrexed—GART—digestive system—Crohn's disease	0.00311	0.0563	CbGeAlD
Pemetrexed—GART—Folate Metabolism—GPX4—Crohn's disease	0.00286	0.0571	CbGpPWpGaD
Pemetrexed—ATIC—epithelium—Crohn's disease	0.00278	0.0503	CbGeAlD
Pemetrexed—ATIC—smooth muscle tissue—Crohn's disease	0.00268	0.0484	CbGeAlD
Pemetrexed—ATIC—skin of body—Crohn's disease	0.00264	0.0478	CbGeAlD
Pemetrexed—SLC46A1—lymphoid tissue—Crohn's disease	0.00256	0.0463	CbGeAlD
Pemetrexed—SLC46A1—digestive system—Crohn's disease	0.00253	0.0457	CbGeAlD
Pemetrexed—TYMS—Diflunisal—Mesalazine—Crohn's disease	0.00247	0.616	CbGdCrCtD
Pemetrexed—Intestinal perforation—Azathioprine—Crohn's disease	0.00235	0.0274	CcSEcCtD
Pemetrexed—GART—Folate Metabolism—MPO—Crohn's disease	0.00218	0.0435	CbGpPWpGaD
Pemetrexed—ATIC—lymphoid tissue—Crohn's disease	0.00214	0.0387	CbGeAlD
Pemetrexed—ATIC—digestive system—Crohn's disease	0.00211	0.0382	CbGeAlD
Pemetrexed—Interstitial pneumonia—Azathioprine—Crohn's disease	0.00192	0.0224	CcSEcCtD
Pemetrexed—TYMS—smooth muscle tissue—Crohn's disease	0.00182	0.0328	CbGeAlD
Pemetrexed—TYMS—skin of body—Crohn's disease	0.00179	0.0324	CbGeAlD
Pemetrexed—DHFR—One Carbon Metabolism—DNMT3A—Crohn's disease	0.00178	0.0356	CbGpPWpGaD
Pemetrexed—GART—lymph node—Crohn's disease	0.00178	0.0322	CbGeAlD
Pemetrexed—Nephropathy—Mesalazine—Crohn's disease	0.00178	0.0207	CcSEcCtD
Pemetrexed—Interstitial pneumonia—Mesalazine—Crohn's disease	0.00175	0.0204	CcSEcCtD
Pemetrexed—TYMS—mammalian vulva—Crohn's disease	0.00164	0.0296	CbGeAlD
Pemetrexed—DHFR—mammalian vulva—Crohn's disease	0.00162	0.0293	CbGeAlD
Pemetrexed—DHFR—Trans-sulfuration and one carbon metabolism—DNMT3A—Crohn's disease	0.0016	0.032	CbGpPWpGaD
Pemetrexed—TYMS—One Carbon Metabolism—DNMT3A—Crohn's disease	0.00155	0.031	CbGpPWpGaD
Pemetrexed—SLC46A1—Folate Metabolism—GPX4—Crohn's disease	0.00154	0.0308	CbGpPWpGaD
Pemetrexed—SLC29A1—mammalian vulva—Crohn's disease	0.00147	0.0265	CbGeAlD
Pemetrexed—TYMS—lymphoid tissue—Crohn's disease	0.00145	0.0263	CbGeAlD
Pemetrexed—SLC46A1—lymph node—Crohn's disease	0.00144	0.0261	CbGeAlD
Pemetrexed—DHFR—lymphoid tissue—Crohn's disease	0.00144	0.026	CbGeAlD
Pemetrexed—TYMS—digestive system—Crohn's disease	0.00143	0.0259	CbGeAlD
Pemetrexed—Platelet count decreased—Mesalazine—Crohn's disease	0.00142	0.0166	CcSEcCtD
Pemetrexed—DHFR—digestive system—Crohn's disease	0.00142	0.0257	CbGeAlD
Pemetrexed—DCK—mammalian vulva—Crohn's disease	0.0014	0.0253	CbGeAlD
Pemetrexed—TYMS—Trans-sulfuration and one carbon metabolism—DNMT3A—Crohn's disease	0.0014	0.0279	CbGpPWpGaD
Pemetrexed—Sepsis—Mercaptopurine—Crohn's disease	0.00135	0.0158	CcSEcCtD
Pemetrexed—Interstitial lung disease—Azathioprine—Crohn's disease	0.00131	0.0153	CcSEcCtD
Pemetrexed—SLC29A1—lymphoid tissue—Crohn's disease	0.0013	0.0235	CbGeAlD
Pemetrexed—SLC29A1—digestive system—Crohn's disease	0.00129	0.0233	CbGeAlD
Pemetrexed—DCK—lymphoid tissue—Crohn's disease	0.00124	0.0225	CbGeAlD
Pemetrexed—DCK—digestive system—Crohn's disease	0.00123	0.0222	CbGeAlD
Pemetrexed—ATIC—lymph node—Crohn's disease	0.00121	0.0218	CbGeAlD
Pemetrexed—Interstitial lung disease—Mesalazine—Crohn's disease	0.00119	0.014	CcSEcCtD
Pemetrexed—Thrombosis—Mesalazine—Crohn's disease	0.00119	0.014	CcSEcCtD
Pemetrexed—SLC46A1—Folate Metabolism—MPO—Crohn's disease	0.00118	0.0235	CbGpPWpGaD
Pemetrexed—GART—Folate Metabolism—CRP—Crohn's disease	0.00115	0.0229	CbGpPWpGaD
Pemetrexed—Neoplasm malignant—Azathioprine—Crohn's disease	0.00109	0.0127	CcSEcCtD
Pemetrexed—GART—Folate Metabolism—ICAM1—Crohn's disease	0.00105	0.021	CbGpPWpGaD
Pemetrexed—Gamma-glutamyltransferase increased—Mesalazine—Crohn's disease	0.00103	0.012	CcSEcCtD
Pemetrexed—Pancreatitis—Mercaptopurine—Crohn's disease	0.000958	0.0112	CcSEcCtD
Pemetrexed—Rectal haemorrhage—Mesalazine—Crohn's disease	0.000936	0.0109	CcSEcCtD
Pemetrexed—Pancytopenia—Mercaptopurine—Crohn's disease	0.000928	0.0108	CcSEcCtD
Pemetrexed—Colitis—Azathioprine—Crohn's disease	0.000891	0.0104	CcSEcCtD
Pemetrexed—GART—Folate Metabolism—ALB—Crohn's disease	0.000878	0.0175	CbGpPWpGaD
Pemetrexed—Stomatitis—Mercaptopurine—Crohn's disease	0.000849	0.00992	CcSEcCtD
Pemetrexed—DHFR—Folate Metabolism—GPX4—Crohn's disease	0.000827	0.0165	CbGpPWpGaD
Pemetrexed—Hepatobiliary disease—Mercaptopurine—Crohn's disease	0.000824	0.00963	CcSEcCtD
Pemetrexed—TYMS—lymph node—Crohn's disease	0.000819	0.0148	CbGeAlD
Pemetrexed—Colitis—Mesalazine—Crohn's disease	0.000812	0.00948	CcSEcCtD
Pemetrexed—DHFR—lymph node—Crohn's disease	0.000811	0.0147	CbGeAlD
Pemetrexed—Skin exfoliation—Mesalazine—Crohn's disease	0.000807	0.00943	CcSEcCtD
Pemetrexed—GART—Folate Metabolism—IFNG—Crohn's disease	0.000801	0.016	CbGpPWpGaD
Pemetrexed—Neuropathy—Mesalazine—Crohn's disease	0.000794	0.00927	CcSEcCtD
Pemetrexed—Febrile neutropenia—Prednisone—Crohn's disease	0.000743	0.00869	CcSEcCtD
Pemetrexed—SLC29A1—lymph node—Crohn's disease	0.000735	0.0133	CbGeAlD
Pemetrexed—GART—Folate Metabolism—IL1B—Crohn's disease	0.000715	0.0143	CbGpPWpGaD
Pemetrexed—DCK—lymph node—Crohn's disease	0.000702	0.0127	CbGeAlD
Pemetrexed—Embolism—Prednisone—Crohn's disease	0.000697	0.00814	CcSEcCtD
Pemetrexed—Alopecia—Mercaptopurine—Crohn's disease	0.000691	0.00808	CcSEcCtD
Pemetrexed—Malnutrition—Mercaptopurine—Crohn's disease	0.000681	0.00796	CcSEcCtD
Pemetrexed—Renal failure acute—Mesalazine—Crohn's disease	0.000665	0.00777	CcSEcCtD
Pemetrexed—DHFR—Folate Metabolism—MPO—Crohn's disease	0.000631	0.0126	CbGpPWpGaD
Pemetrexed—Anaemia—Mercaptopurine—Crohn's disease	0.000629	0.00735	CcSEcCtD
Pemetrexed—SLC46A1—Folate Metabolism—CRP—Crohn's disease	0.000619	0.0124	CbGpPWpGaD
Pemetrexed—Leukopenia—Mercaptopurine—Crohn's disease	0.000609	0.00712	CcSEcCtD
Pemetrexed—Toxic epidermal necrolysis—Azathioprine—Crohn's disease	0.000607	0.00709	CcSEcCtD
Pemetrexed—Neuritis—Prednisone—Crohn's disease	0.000599	0.007	CcSEcCtD
Pemetrexed—SLC29A1—Transport of vitamins, nucleosides, and related molecules—ALB—Crohn's disease	0.000585	0.0117	CbGpPWpGaD
Pemetrexed—Mood swings—Mesalazine—Crohn's disease	0.000581	0.00679	CcSEcCtD
Pemetrexed—Arthralgia—Mercaptopurine—Crohn's disease	0.00058	0.00677	CcSEcCtD
Pemetrexed—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—Crohn's disease	0.000576	0.00673	CcSEcCtD
Pemetrexed—Blood creatinine increased—Mesalazine—Crohn's disease	0.000575	0.00672	CcSEcCtD
Pemetrexed—Pancreatitis—Azathioprine—Crohn's disease	0.000571	0.00667	CcSEcCtD
Pemetrexed—SLC46A1—Folate Metabolism—ICAM1—Crohn's disease	0.000569	0.0114	CbGpPWpGaD
Pemetrexed—SLC29A1—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	0.00056	0.0112	CbGpPWpGaD
Pemetrexed—SLC29A1—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.00056	0.0112	CbGpPWpGaD
Pemetrexed—Oedema—Mercaptopurine—Crohn's disease	0.000556	0.00649	CcSEcCtD
Pemetrexed—Pancytopenia—Azathioprine—Crohn's disease	0.000553	0.00646	CcSEcCtD
Pemetrexed—Aspartate aminotransferase increased—Mesalazine—Crohn's disease	0.000552	0.00646	CcSEcCtD
Pemetrexed—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.000544	0.00636	CcSEcCtD
Pemetrexed—Alanine aminotransferase increased—Mesalazine—Crohn's disease	0.000541	0.00632	CcSEcCtD
Pemetrexed—Skin disorder—Mercaptopurine—Crohn's disease	0.00054	0.00631	CcSEcCtD
Pemetrexed—Dysphagia—Mesalazine—Crohn's disease	0.00053	0.0062	CcSEcCtD
Pemetrexed—Anorexia—Mercaptopurine—Crohn's disease	0.00053	0.00619	CcSEcCtD
Pemetrexed—Pancreatitis—Mesalazine—Crohn's disease	0.00052	0.00608	CcSEcCtD
Pemetrexed—Infestation—Azathioprine—Crohn's disease	0.000519	0.00607	CcSEcCtD
Pemetrexed—Infestation NOS—Azathioprine—Crohn's disease	0.000519	0.00607	CcSEcCtD
Pemetrexed—GART—Folate Metabolism—TNF—Crohn's disease	0.000519	0.0104	CbGpPWpGaD
Pemetrexed—Angina pectoris—Mesalazine—Crohn's disease	0.000517	0.00604	CcSEcCtD
Pemetrexed—Stevens-Johnson syndrome—Azathioprine—Crohn's disease	0.000515	0.00601	CcSEcCtD
Pemetrexed—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.000506	0.00592	CcSEcCtD
Pemetrexed—Pancytopenia—Mesalazine—Crohn's disease	0.000504	0.00589	CcSEcCtD
Pemetrexed—Neutropenia—Mesalazine—Crohn's disease	0.000496	0.0058	CcSEcCtD
Pemetrexed—Hepatobiliary disease—Azathioprine—Crohn's disease	0.000491	0.00574	CcSEcCtD
Pemetrexed—Agranulocytosis—Azathioprine—Crohn's disease	0.000484	0.00566	CcSEcCtD
Pemetrexed—Decreased appetite—Mercaptopurine—Crohn's disease	0.000483	0.00564	CcSEcCtD
Pemetrexed—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.00048	0.00561	CcSEcCtD
Pemetrexed—TYMS—Circadian rythm related genes—CREM—Crohn's disease	0.000477	0.00954	CbGpPWpGaD
Pemetrexed—SLC46A1—Folate Metabolism—ALB—Crohn's disease	0.000474	0.00948	CbGpPWpGaD
Pemetrexed—Infestation NOS—Mesalazine—Crohn's disease	0.000473	0.00553	CcSEcCtD
Pemetrexed—Infestation—Mesalazine—Crohn's disease	0.000473	0.00553	CcSEcCtD
Pemetrexed—Stevens-Johnson syndrome—Mesalazine—Crohn's disease	0.000469	0.00548	CcSEcCtD
Pemetrexed—Renal failure—Mesalazine—Crohn's disease	0.000465	0.00543	CcSEcCtD
Pemetrexed—Neuropathy peripheral—Mesalazine—Crohn's disease	0.000463	0.00542	CcSEcCtD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—MST1—Crohn's disease	0.000462	0.00924	CbGpPWpGaD
Pemetrexed—Stomatitis—Mesalazine—Crohn's disease	0.000461	0.00539	CcSEcCtD
Pemetrexed—Conjunctivitis—Mesalazine—Crohn's disease	0.00046	0.00537	CcSEcCtD
Pemetrexed—Hepatobiliary disease—Mesalazine—Crohn's disease	0.000447	0.00523	CcSEcCtD
Pemetrexed—Agranulocytosis—Mesalazine—Crohn's disease	0.000441	0.00516	CcSEcCtD
Pemetrexed—Erythema multiforme—Azathioprine—Crohn's disease	0.000441	0.00515	CcSEcCtD
Pemetrexed—Body temperature increased—Mercaptopurine—Crohn's disease	0.000439	0.00513	CcSEcCtD
Pemetrexed—SLC46A1—Folate Metabolism—IFNG—Crohn's disease	0.000433	0.00865	CbGpPWpGaD
Pemetrexed—Skin exfoliation—Prednisone—Crohn's disease	0.000427	0.00499	CcSEcCtD
Pemetrexed—Hepatitis—Mesalazine—Crohn's disease	0.000424	0.00496	CcSEcCtD
Pemetrexed—Pharyngitis—Mesalazine—Crohn's disease	0.000421	0.00492	CcSEcCtD
Pemetrexed—Neuropathy—Prednisone—Crohn's disease	0.00042	0.00491	CcSEcCtD
Pemetrexed—Urinary tract disorder—Mesalazine—Crohn's disease	0.000419	0.0049	CcSEcCtD
Pemetrexed—GART—Folate Metabolism—IL6—Crohn's disease	0.000419	0.00836	CbGpPWpGaD
Pemetrexed—Arrhythmia—Azathioprine—Crohn's disease	0.000416	0.00486	CcSEcCtD
Pemetrexed—Urethral disorder—Mesalazine—Crohn's disease	0.000416	0.00486	CcSEcCtD
Pemetrexed—Alopecia—Azathioprine—Crohn's disease	0.000412	0.00481	CcSEcCtD
Pemetrexed—Hypersensitivity—Mercaptopurine—Crohn's disease	0.000409	0.00478	CcSEcCtD
Pemetrexed—Oesophagitis—Prednisone—Crohn's disease	0.000409	0.00478	CcSEcCtD
Pemetrexed—Erythema multiforme—Mesalazine—Crohn's disease	0.000401	0.00469	CcSEcCtD
Pemetrexed—Eye disorder—Mesalazine—Crohn's disease	0.000397	0.00464	CcSEcCtD
Pemetrexed—SLC29A1—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.000395	0.00788	CbGpPWpGaD
Pemetrexed—Sepsis—Prednisone—Crohn's disease	0.000388	0.00454	CcSEcCtD
Pemetrexed—SLC46A1—Folate Metabolism—IL1B—Crohn's disease	0.000386	0.00771	CbGpPWpGaD
Pemetrexed—Diarrhoea—Mercaptopurine—Crohn's disease	0.00038	0.00444	CcSEcCtD
Pemetrexed—Alopecia—Mesalazine—Crohn's disease	0.000375	0.00438	CcSEcCtD
Pemetrexed—Anaemia—Azathioprine—Crohn's disease	0.000375	0.00438	CcSEcCtD
Pemetrexed—Erythema—Mesalazine—Crohn's disease	0.000369	0.00432	CcSEcCtD
Pemetrexed—GART—Metabolism—PLA2G4F—Crohn's disease	0.000366	0.00732	CbGpPWpGaD
Pemetrexed—Leukopenia—Azathioprine—Crohn's disease	0.000363	0.00424	CcSEcCtD
Pemetrexed—Dysgeusia—Mesalazine—Crohn's disease	0.000362	0.00423	CcSEcCtD
Pemetrexed—SLC46A1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000359	0.00717	CbGpPWpGaD
Pemetrexed—SLC46A1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000359	0.00717	CbGpPWpGaD
Pemetrexed—Vomiting—Mercaptopurine—Crohn's disease	0.000353	0.00413	CcSEcCtD
Pemetrexed—Rash—Mercaptopurine—Crohn's disease	0.00035	0.00409	CcSEcCtD
Pemetrexed—Dermatitis—Mercaptopurine—Crohn's disease	0.00035	0.00409	CcSEcCtD
Pemetrexed—SLC29A1—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.000349	0.00697	CbGpPWpGaD
Pemetrexed—Arthralgia—Azathioprine—Crohn's disease	0.000345	0.00404	CcSEcCtD
Pemetrexed—Myalgia—Azathioprine—Crohn's disease	0.000345	0.00404	CcSEcCtD
Pemetrexed—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.000343	0.00401	CcSEcCtD
Pemetrexed—Anaemia—Mesalazine—Crohn's disease	0.000342	0.00399	CcSEcCtD
Pemetrexed—SLC46A1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—Crohn's disease	0.000333	0.00665	CbGpPWpGaD
Pemetrexed—DHFR—Folate Metabolism—CRP—Crohn's disease	0.000332	0.00663	CbGpPWpGaD
Pemetrexed—Syncope—Mesalazine—Crohn's disease	0.000331	0.00387	CcSEcCtD
Pemetrexed—Leukopenia—Mesalazine—Crohn's disease	0.000331	0.00387	CcSEcCtD
Pemetrexed—Nausea—Mercaptopurine—Crohn's disease	0.00033	0.00386	CcSEcCtD
Pemetrexed—Infection—Azathioprine—Crohn's disease	0.000329	0.00384	CcSEcCtD
Pemetrexed—Loss of consciousness—Mesalazine—Crohn's disease	0.000325	0.0038	CcSEcCtD
Pemetrexed—Thrombocytopenia—Azathioprine—Crohn's disease	0.000324	0.00379	CcSEcCtD
Pemetrexed—Skin disorder—Azathioprine—Crohn's disease	0.000322	0.00376	CcSEcCtD
Pemetrexed—Hypertension—Mesalazine—Crohn's disease	0.000319	0.00373	CcSEcCtD
Pemetrexed—Chest pain—Mesalazine—Crohn's disease	0.000315	0.00368	CcSEcCtD
Pemetrexed—Myalgia—Mesalazine—Crohn's disease	0.000315	0.00368	CcSEcCtD
Pemetrexed—Arthralgia—Mesalazine—Crohn's disease	0.000315	0.00368	CcSEcCtD
Pemetrexed—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.000312	0.00365	CcSEcCtD
Pemetrexed—GART—Metabolism—MTMR3—Crohn's disease	0.000311	0.00622	CbGpPWpGaD
Pemetrexed—Mood swings—Prednisone—Crohn's disease	0.000308	0.00359	CcSEcCtD
Pemetrexed—DHFR—Folate Metabolism—ICAM1—Crohn's disease	0.000305	0.00609	CbGpPWpGaD
Pemetrexed—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.000302	0.00353	CcSEcCtD
Pemetrexed—Anaphylactic shock—Mesalazine—Crohn's disease	0.000302	0.00352	CcSEcCtD
Pemetrexed—Oedema—Mesalazine—Crohn's disease	0.000302	0.00352	CcSEcCtD
Pemetrexed—Infection—Mesalazine—Crohn's disease	0.0003	0.0035	CcSEcCtD
Pemetrexed—Shock—Mesalazine—Crohn's disease	0.000297	0.00347	CcSEcCtD
Pemetrexed—Nervous system disorder—Mesalazine—Crohn's disease	0.000296	0.00346	CcSEcCtD
Pemetrexed—Thrombocytopenia—Mesalazine—Crohn's disease	0.000295	0.00345	CcSEcCtD
Pemetrexed—Skin disorder—Mesalazine—Crohn's disease	0.000293	0.00342	CcSEcCtD
Pemetrexed—Anorexia—Mesalazine—Crohn's disease	0.000287	0.00336	CcSEcCtD
Pemetrexed—Alanine aminotransferase increased—Prednisone—Crohn's disease	0.000286	0.00335	CcSEcCtD
Pemetrexed—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.000286	0.00334	CcSEcCtD
Pemetrexed—SLC29A1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000285	0.00569	CbGpPWpGaD
Pemetrexed—SLC29A1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000285	0.00569	CbGpPWpGaD
Pemetrexed—SLC46A1—Folate Metabolism—TNF—Crohn's disease	0.00028	0.0056	CbGpPWpGaD
Pemetrexed—Pancreatitis—Prednisone—Crohn's disease	0.000275	0.00321	CcSEcCtD
Pemetrexed—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.000275	0.00321	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Azathioprine—Crohn's disease	0.000271	0.00316	CcSEcCtD
Pemetrexed—Dyspnoea—Mesalazine—Crohn's disease	0.000269	0.00314	CcSEcCtD
Pemetrexed—Dyspepsia—Mesalazine—Crohn's disease	0.000265	0.0031	CcSEcCtD
Pemetrexed—Neutropenia—Prednisone—Crohn's disease	0.000262	0.00307	CcSEcCtD
Pemetrexed—Decreased appetite—Mesalazine—Crohn's disease	0.000262	0.00306	CcSEcCtD
Pemetrexed—Body temperature increased—Azathioprine—Crohn's disease	0.000262	0.00306	CcSEcCtD
Pemetrexed—Abdominal pain—Azathioprine—Crohn's disease	0.000262	0.00306	CcSEcCtD
Pemetrexed—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.00026	0.00304	CcSEcCtD
Pemetrexed—Fatigue—Mesalazine—Crohn's disease	0.00026	0.00304	CcSEcCtD
Pemetrexed—Pain—Mesalazine—Crohn's disease	0.000258	0.00301	CcSEcCtD
Pemetrexed—Constipation—Mesalazine—Crohn's disease	0.000258	0.00301	CcSEcCtD
Pemetrexed—DHFR—Folate Metabolism—ALB—Crohn's disease	0.000254	0.00508	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—PLA2G4F—Crohn's disease	0.000254	0.00507	CbGpPWpGaD
Pemetrexed—SLC46A1—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.000253	0.00505	CbGpPWpGaD
Pemetrexed—Acute coronary syndrome—Prednisone—Crohn's disease	0.000247	0.00288	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Mesalazine—Crohn's disease	0.000247	0.00288	CcSEcCtD
Pemetrexed—Myocardial infarction—Prednisone—Crohn's disease	0.000245	0.00287	CcSEcCtD
Pemetrexed—Neuropathy peripheral—Prednisone—Crohn's disease	0.000245	0.00287	CcSEcCtD
Pemetrexed—Hypersensitivity—Azathioprine—Crohn's disease	0.000244	0.00285	CcSEcCtD
Pemetrexed—GART—Metabolism—FADS1—Crohn's disease	0.000243	0.00485	CbGpPWpGaD
Pemetrexed—DCK—Desoximetasone—Prednisone—Crohn's disease	0.000242	0.0603	CbGdCrCtD
Pemetrexed—Urticaria—Mesalazine—Crohn's disease	0.00024	0.0028	CcSEcCtD
Pemetrexed—Abdominal pain—Mesalazine—Crohn's disease	0.000238	0.00279	CcSEcCtD
Pemetrexed—Body temperature increased—Mesalazine—Crohn's disease	0.000238	0.00279	CcSEcCtD
Pemetrexed—DCK—Diflorasone—Prednisone—Crohn's disease	0.000235	0.0586	CbGdCrCtD
Pemetrexed—DHFR—Folate Metabolism—IFNG—Crohn's disease	0.000232	0.00464	CbGpPWpGaD
Pemetrexed—GART—Metabolism—GPX4—Crohn's disease	0.000227	0.00454	CbGpPWpGaD
Pemetrexed—Diarrhoea—Azathioprine—Crohn's disease	0.000227	0.00265	CcSEcCtD
Pemetrexed—SLC46A1—Folate Metabolism—IL6—Crohn's disease	0.000226	0.00452	CbGpPWpGaD
Pemetrexed—SLC46A1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.000224	0.00447	CbGpPWpGaD
Pemetrexed—Hypersensitivity—Mesalazine—Crohn's disease	0.000222	0.0026	CcSEcCtD
Pemetrexed—GART—Metabolism—GCKR—Crohn's disease	0.000219	0.00438	CbGpPWpGaD
Pemetrexed—Dizziness—Azathioprine—Crohn's disease	0.000219	0.00256	CcSEcCtD
Pemetrexed—Asthenia—Mesalazine—Crohn's disease	0.000216	0.00253	CcSEcCtD
Pemetrexed—ATIC—Metabolism—MTMR3—Crohn's disease	0.000216	0.00431	CbGpPWpGaD
Pemetrexed—Pruritus—Mesalazine—Crohn's disease	0.000213	0.00249	CcSEcCtD
Pemetrexed—Vomiting—Azathioprine—Crohn's disease	0.00021	0.00246	CcSEcCtD
Pemetrexed—Eye disorder—Prednisone—Crohn's disease	0.00021	0.00245	CcSEcCtD
Pemetrexed—Rash—Azathioprine—Crohn's disease	0.000209	0.00244	CcSEcCtD
Pemetrexed—Dermatitis—Azathioprine—Crohn's disease	0.000209	0.00244	CcSEcCtD
Pemetrexed—DHFR—Folate Metabolism—IL1B—Crohn's disease	0.000207	0.00414	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—RSPO3—Crohn's disease	0.000206	0.00412	CbGpPWpGaD
Pemetrexed—Diarrhoea—Mesalazine—Crohn's disease	0.000206	0.00241	CcSEcCtD
Pemetrexed—Arrhythmia—Prednisone—Crohn's disease	0.000201	0.00234	CcSEcCtD
Pemetrexed—SLC29A1—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.000201	0.00401	CbGpPWpGaD
Pemetrexed—Dizziness—Mesalazine—Crohn's disease	0.000199	0.00233	CcSEcCtD
Pemetrexed—Alopecia—Prednisone—Crohn's disease	0.000198	0.00232	CcSEcCtD
Pemetrexed—SLC46A1—Metabolism—PLA2G4F—Crohn's disease	0.000198	0.00395	CbGpPWpGaD
Pemetrexed—Nausea—Azathioprine—Crohn's disease	0.000197	0.0023	CcSEcCtD
Pemetrexed—TYMS—Clobetasol propionate—Prednisone—Crohn's disease	0.000196	0.049	CbGdCrCtD
Pemetrexed—SLC46A1—Disease—SEL1L—Crohn's disease	0.000196	0.00391	CbGpPWpGaD
Pemetrexed—Erythema—Prednisone—Crohn's disease	0.000195	0.00228	CcSEcCtD
Pemetrexed—Malnutrition—Prednisone—Crohn's disease	0.000195	0.00228	CcSEcCtD
Pemetrexed—TYMS—Flunisolide—Prednisone—Crohn's disease	0.000194	0.0483	CbGdCrCtD
Pemetrexed—Vomiting—Mesalazine—Crohn's disease	0.000192	0.00224	CcSEcCtD
Pemetrexed—TYMS—Triamcinolone—Prednisone—Crohn's disease	0.000192	0.0478	CbGdCrCtD
Pemetrexed—Rash—Mesalazine—Crohn's disease	0.00019	0.00222	CcSEcCtD
Pemetrexed—Dermatitis—Mesalazine—Crohn's disease	0.00019	0.00222	CcSEcCtD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	0.000187	0.00374	CbGpPWpGaD
Pemetrexed—Anaemia—Prednisone—Crohn's disease	0.000181	0.00211	CcSEcCtD
Pemetrexed—Nausea—Mesalazine—Crohn's disease	0.000179	0.00209	CcSEcCtD
Pemetrexed—DHFR—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—Crohn's disease	0.000178	0.00356	CbGpPWpGaD
Pemetrexed—SLC29A1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.000177	0.00354	CbGpPWpGaD
Pemetrexed—TYMS—Diflorasone—Prednisone—Crohn's disease	0.000177	0.0441	CbGdCrCtD
Pemetrexed—SLC46A1—Disease—LTF—Crohn's disease	0.000175	0.00351	CbGpPWpGaD
Pemetrexed—Syncope—Prednisone—Crohn's disease	0.000175	0.00205	CcSEcCtD
Pemetrexed—Loss of consciousness—Prednisone—Crohn's disease	0.000172	0.00201	CcSEcCtD
Pemetrexed—Hypertension—Prednisone—Crohn's disease	0.000169	0.00197	CcSEcCtD
Pemetrexed—SLC46A1—Metabolism—MTMR3—Crohn's disease	0.000168	0.00336	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—FADS1—Crohn's disease	0.000168	0.00336	CbGpPWpGaD
Pemetrexed—Myalgia—Prednisone—Crohn's disease	0.000166	0.00195	CcSEcCtD
Pemetrexed—Arthralgia—Prednisone—Crohn's disease	0.000166	0.00195	CcSEcCtD
Pemetrexed—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	0.000165	0.00193	CcSEcCtD
Pemetrexed—Oedema—Prednisone—Crohn's disease	0.00016	0.00186	CcSEcCtD
Pemetrexed—Anaphylactic shock—Prednisone—Crohn's disease	0.00016	0.00186	CcSEcCtD
Pemetrexed—Infection—Prednisone—Crohn's disease	0.000159	0.00185	CcSEcCtD
Pemetrexed—ATIC—Metabolism—GPX4—Crohn's disease	0.000157	0.00315	CbGpPWpGaD
Pemetrexed—Shock—Prednisone—Crohn's disease	0.000157	0.00183	CcSEcCtD
Pemetrexed—Nervous system disorder—Prednisone—Crohn's disease	0.000156	0.00183	CcSEcCtD
Pemetrexed—Skin disorder—Prednisone—Crohn's disease	0.000155	0.00181	CcSEcCtD
Pemetrexed—TYMS—Budesonide—Prednisone—Crohn's disease	0.000155	0.0386	CbGdCrCtD
Pemetrexed—Anorexia—Prednisone—Crohn's disease	0.000152	0.00178	CcSEcCtD
Pemetrexed—ATIC—Metabolism—GCKR—Crohn's disease	0.000152	0.00304	CbGpPWpGaD
Pemetrexed—DHFR—Folate Metabolism—TNF—Crohn's disease	0.00015	0.003	CbGpPWpGaD
Pemetrexed—TYMS—Danazol—Prednisone—Crohn's disease	0.000148	0.037	CbGdCrCtD
Pemetrexed—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.000145	0.0017	CcSEcCtD
Pemetrexed—SLC46A1—Disease—GCKR—Crohn's disease	0.000141	0.00283	CbGpPWpGaD
Pemetrexed—Dyspepsia—Prednisone—Crohn's disease	0.00014	0.00164	CcSEcCtD
Pemetrexed—Decreased appetite—Prednisone—Crohn's disease	0.000139	0.00162	CcSEcCtD
Pemetrexed—Fatigue—Prednisone—Crohn's disease	0.000138	0.00161	CcSEcCtD
Pemetrexed—Constipation—Prednisone—Crohn's disease	0.000136	0.00159	CcSEcCtD
Pemetrexed—DCK—Metabolism—PLA2G4F—Crohn's disease	0.000132	0.00264	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—FADS1—Crohn's disease	0.000131	0.00262	CbGpPWpGaD
Pemetrexed—Gastrointestinal pain—Prednisone—Crohn's disease	0.00013	0.00152	CcSEcCtD
Pemetrexed—Urticaria—Prednisone—Crohn's disease	0.000127	0.00148	CcSEcCtD
Pemetrexed—Body temperature increased—Prednisone—Crohn's disease	0.000126	0.00147	CcSEcCtD
Pemetrexed—Abdominal pain—Prednisone—Crohn's disease	0.000126	0.00147	CcSEcCtD
Pemetrexed—SLC29A1—SLC-mediated transmembrane transport—ALB—Crohn's disease	0.000126	0.00251	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—SLC11A1—Crohn's disease	0.000125	0.0025	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—GPX4—Crohn's disease	0.000123	0.00245	CbGpPWpGaD
Pemetrexed—DHFR—Folate Metabolism—IL6—Crohn's disease	0.000121	0.00242	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—GCKR—Crohn's disease	0.000118	0.00237	CbGpPWpGaD
Pemetrexed—Hypersensitivity—Prednisone—Crohn's disease	0.000118	0.00137	CcSEcCtD
Pemetrexed—Asthenia—Prednisone—Crohn's disease	0.000114	0.00134	CcSEcCtD
Pemetrexed—Pruritus—Prednisone—Crohn's disease	0.000113	0.00132	CcSEcCtD
Pemetrexed—DCK—Metabolism—MTMR3—Crohn's disease	0.000112	0.00224	CbGpPWpGaD
Pemetrexed—DHFR—Disease—RSPO3—Crohn's disease	0.000111	0.00221	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle, Mitotic—UBE2D1—Crohn's disease	0.00011	0.0022	CbGpPWpGaD
Pemetrexed—Diarrhoea—Prednisone—Crohn's disease	0.000109	0.00128	CcSEcCtD
Pemetrexed—SLC46A1—Disease—RBX1—Crohn's disease	0.000107	0.00214	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—HSPA1B—Crohn's disease	0.000107	0.00214	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—PLA2G4F—Crohn's disease	0.000106	0.00212	CbGpPWpGaD
Pemetrexed—Dizziness—Prednisone—Crohn's disease	0.000106	0.00123	CcSEcCtD
Pemetrexed—DHFR—Disease—SEL1L—Crohn's disease	0.000105	0.0021	CbGpPWpGaD
Pemetrexed—Vomiting—Prednisone—Crohn's disease	0.000101	0.00119	CcSEcCtD
Pemetrexed—Rash—Prednisone—Crohn's disease	0.000101	0.00118	CcSEcCtD
Pemetrexed—Dermatitis—Prednisone—Crohn's disease	0.000101	0.00117	CcSEcCtD
Pemetrexed—DHFR—Cell Cycle—UBE2D1—Crohn's disease	9.82e-05	0.00196	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle, Mitotic—UBE2D1—Crohn's disease	9.59e-05	0.00192	CbGpPWpGaD
Pemetrexed—Nausea—Prednisone—Crohn's disease	9.48e-05	0.00111	CcSEcCtD
Pemetrexed—DHFR—Disease—LTF—Crohn's disease	9.41e-05	0.00188	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—UBE2D1—Crohn's disease	9.4e-05	0.00188	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—PLA2G4F—Crohn's disease	9.25e-05	0.00185	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—MTMR3—Crohn's disease	9.01e-05	0.0018	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—FADS1—Crohn's disease	8.74e-05	0.00175	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—UBE2D1—Crohn's disease	8.57e-05	0.00171	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	8.3e-05	0.00166	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—GPX4—Crohn's disease	8.18e-05	0.00163	CbGpPWpGaD
Pemetrexed—SLC46A1—Transmembrane transport of small molecules—ALB—Crohn's disease	8.05e-05	0.00161	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—GCKR—Crohn's disease	7.9e-05	0.00158	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—MTMR3—Crohn's disease	7.87e-05	0.00157	CbGpPWpGaD
Pemetrexed—DHFR—Disease—GCKR—Crohn's disease	7.58e-05	0.00152	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—FADS1—Crohn's disease	7.02e-05	0.0014	CbGpPWpGaD
Pemetrexed—GART—Metabolism—ALB—Crohn's disease	6.98e-05	0.00139	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—SMAD3—Crohn's disease	6.72e-05	0.00134	CbGpPWpGaD
Pemetrexed—DHFR—Disease—SLC11A1—Crohn's disease	6.7e-05	0.00134	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—GPX4—Crohn's disease	6.58e-05	0.00131	CbGpPWpGaD
Pemetrexed—SLC29A1—Transmembrane transport of small molecules—ALB—Crohn's disease	6.38e-05	0.00128	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—GCKR—Crohn's disease	6.35e-05	0.00127	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—FADS1—Crohn's disease	6.13e-05	0.00122	CbGpPWpGaD
Pemetrexed—GART—Metabolism—PTGS2—Crohn's disease	6.11e-05	0.00122	CbGpPWpGaD
Pemetrexed—DHFR—Disease—RBX1—Crohn's disease	5.75e-05	0.00115	CbGpPWpGaD
Pemetrexed—DHFR—Disease—HSPA1B—Crohn's disease	5.75e-05	0.00115	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—GPX4—Crohn's disease	5.74e-05	0.00115	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	5.6e-05	0.00112	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—GCKR—Crohn's disease	5.54e-05	0.00111	CbGpPWpGaD
Pemetrexed—DHFR—Disease—UBE2D1—Crohn's disease	5.04e-05	0.00101	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—ALB—Crohn's disease	4.84e-05	0.000967	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—TYK2—Crohn's disease	4.39e-05	0.000876	CbGpPWpGaD
Pemetrexed—TYMS—Circadian rythm related genes—IL6—Crohn's disease	4.34e-05	0.000867	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—PTGS2—Crohn's disease	4.23e-05	0.000846	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—JAK2—Crohn's disease	4.18e-05	0.000836	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—CD4—Crohn's disease	3.97e-05	0.000793	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—PTGS2—Crohn's disease	3.94e-05	0.000787	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—ALB—Crohn's disease	3.77e-05	0.000753	CbGpPWpGaD
Pemetrexed—DHFR—Disease—SMAD3—Crohn's disease	3.61e-05	0.00072	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—PTGS2—Crohn's disease	3.3e-05	0.000659	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—STAT3—Crohn's disease	3.07e-05	0.000614	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—ALB—Crohn's disease	2.52e-05	0.000503	CbGpPWpGaD
Pemetrexed—DHFR—Disease—TYK2—Crohn's disease	2.35e-05	0.00047	CbGpPWpGaD
Pemetrexed—DHFR—Disease—JAK2—Crohn's disease	2.24e-05	0.000448	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—PTGS2—Crohn's disease	2.2e-05	0.00044	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—IL6—Crohn's disease	2.15e-05	0.000429	CbGpPWpGaD
Pemetrexed—DHFR—Disease—CD4—Crohn's disease	2.13e-05	0.000425	CbGpPWpGaD
Pemetrexed—DHFR—Disease—PTGS2—Crohn's disease	2.11e-05	0.000422	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—ALB—Crohn's disease	2.02e-05	0.000404	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—PTGS2—Crohn's disease	1.77e-05	0.000353	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—ALB—Crohn's disease	1.76e-05	0.000352	CbGpPWpGaD
Pemetrexed—DHFR—Disease—STAT3—Crohn's disease	1.65e-05	0.000329	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—PTGS2—Crohn's disease	1.54e-05	0.000308	CbGpPWpGaD
Pemetrexed—DHFR—Disease—IL6—Crohn's disease	1.15e-05	0.00023	CbGpPWpGaD
